Canmab 440 mg Injection

Canmab 440 mg Injection contains Trastuzumab, a monoclonal antibody that specifically targets HER2-positive breast and gastric cancer, slowing tumor growth and improving survival rates.

Uses:

✔ HER2-Positive Breast Cancer – Helps shrink and slow the growth of HER2-positive tumors.
✔ HER2-Positive Gastric Cancer – Used in combination therapy for advanced stomach cancer.

How Canmab 440 mg Works:

Trastuzumab binds to HER2 receptors on cancer cells, blocking growth signals and enhancing the immune system’s ability to destroy them.

Common Side Effects:

🔹 Fever & chills
🔹 Fatigue
🔹 Nausea & vomiting
🔹 Diarrhea

Serious Side Effects (Seek Medical Help):

⚠️ Heart complications (weakened heart function, heart failure)
⚠️ Lung issues (breathing difficulties, inflammation)
⚠️ Infusion reactions (allergic responses, rash, swelling)

Precautions:

⚡ Pregnancy & Breastfeeding: Not recommended; may cause birth defects.
⚡ Heart Monitoring: Patients require regular heart function tests before and during treatment.
⚡ Infusion Reactions: Pre-medication with antihistamines may be required.

FAQs:

1. How is Canmab 440 mg Injection administered?
It is given as an intravenous infusion under medical supervision.

2. Can Canmab 440 mg be used with chemotherapy?
Yes, it is often combined with chemotherapy for better treatment results.

3. How long does treatment with Canmab last?
Typically, 6 months to 1 year, depending on individual response and medical guidelines.

4. Is Canmab 440 mg a cure for cancer?
It slows progression and improves survival, but does not guarantee a cure.

5. Where can I buy Canmab 440 mg Injection online?
Order from Milan Medicals for authentic products, best prices, and fast delivery.

References:

🔗 https://www.cancerresearchuk.org/about-cancer/treatment/drugs/trastuzumab
🔗 https://medlineplus.gov/druginfo/meds/a699019.html